Cacti Therapeutics
PrivateLast Round
Accelerator
Jan 1, 2024
Total Funding Raised
$100,000
Company Overview
Cacti Therapeutics is a biotechnology company developing novel non-addictive pharmaceutical therapies for chronic pain, inflammation, and opioid use disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cacti Therapeutics Comparables
Compare Cacti Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ella LeRoy Corporation | 79% |
For institutional investors. Book with your work email.
Cacti Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cacti Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Factory | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2025
Grew 93% QoQ from 15 to 29 employees.
- Jan 18, 2025
Grew 75% QoQ from 16 to 28 employees.
For institutional investors. Book with your work email.
Cacti Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cacti Therapeutics's valuation, stock price, and market status.
Is Cacti Therapeutics a public or private company?
Cacti Therapeutics is a private company.
What is the current stock price of Cacti Therapeutics?
Cacti Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cacti Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cacti Therapeutics worth (valuation)?
Valuation information for Cacti Therapeutics is not publicly available.
Can I buy Cacti Therapeutics stock?
Cacti Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cacti Therapeutics's last funding round?
Cacti Therapeutics's most recent funding round was Accelerator on January 1, 2024.
Who are the main investors in Cacti Therapeutics?
Key investors in Cacti Therapeutics include Capital Factory.
Will Cacti Therapeutics IPO soon?
No public IPO plans have been announced for Cacti Therapeutics.
How can I track Cacti Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cacti Therapeutics's shares on secondary markets.